Drugs Xagena
Tumour necrosis factor alpha ( TNF-alpha ) is a cellular protein produced by the immune system and is an important mediator of many diseases, including inflammatory arthritis and inflammatory bowel di ...
Safety reviews of tumor necrosis factor-alpha ( TNF-a ) antagonists, Infliximab ( Remicade ), Etanercept ( Enbrel ), and Adalimumab ( Humira ) identified rare cases of serious skin reactions, includin ...
Tumor necrosis factor a ( TNF- alpha ) blockade has emerged as a useful therapy for collagen vascular diseases or graft-vs-host disease. Fungal infections complicating such therapy have been reported ...
Inflectra, a biosimilar medicine to the reference medicinal product, Remicade ( Infliximab ), has been approved for the treatment of inflammatory conditions including rheumatoid arthritis, ankylosing ...
The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Remsima, 100 mg powder for ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use ( CHMP ) has recommended granting of marketing authorisations for the first two monoclonal-antibody biosimilars.Remsima a ...
The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Inflectra, 100 mg powder fo ...
